UNSPSC 85893664: High dose rate (hdr) brachytherapy of ureter using cesium 137 (cs-137)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of ureter using cesium 137 (cs-137). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DT1197Z

UNSPSC 85893664 High dose rate brachytherapy of ureter using cesium 137, a Commodity code, shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's technical description targets a specific oncology treatment modality, yet the recent solicitation activity recorded under it is entirely unrelated to cancer therapy or medical device procurement — instead capturing temporary health professional staffing services for clinical support roles across multiple specialties.

The County of Santa Clara Health System issued the only recent opportunity on record (RFSQHHSF270052, RFQ, due October 7, 2026), establishing a non-exclusive qualified-vendor pool for temporary staffing in ancillary clinical categories including Audiology, Cardiology and Vascular, Diagnostic Imaging/Radiology, Gastroenterology, Health Services Assistant, Medical Social Worker, Ophthalmology, Orthopedic, Patient Transporter, Respiratory Care, Sterile Processing, Surgical/Operating Room/Labor and Delivery, and Therapy Services. This represents personnel placement, not the therapeutic equipment or services the UNSPSC commodity code nominally describes. The Santa Clara solicitation explicitly excludes nursing, physician, and other non-clinical staffing, and does not guarantee contract awards or work volume to vendors placed on the qualified list. Because the recent opportunity is plainly unrelated to high-dose-rate brachytherapy treatment, this code shows little relevant procurement activity in the state and local market today. Vendors pursuing actual brachytherapy services or oncology-related medical contracting should verify coding alignment with specific issuing bodies before responding to solicitations tagged under this commodity.